MRL VENTURES FUND
Focus on private, pre-clinical stage therapeutics
Calling all pre-clinical therapeutic companies!
LaunchBio and Silicon Valley Bank are pleased to announce their first Investor Connect virtual event with MRL Ventures Fund. MRL Ventures Fund has committed over $500 million in capital, seen $4+ billion in acquisitions in the past four years and funded over 25 clinical trials for their portfolio companies.
MRL Ventures Fund is interested in meeting private, pre-clinical stage therapeutic companies developing novel therapeutics. If this sounds like you, here’s your chance to get connected in a highly personal way while gaining exposure, doing a 1-minute quick pitch, and participating in a Q&A with the investor.
Applications will be selected based on meeting the following criteria:
- Therapeutic Companies
- Any Therapeutic Area
- Preclinical Stage
- Privately Owned
- Novel Approaches Only
- Seeking Seed, Series A or Series B
For more details on LaunchBio’s Investor Connect series in partnership with Silicon Valley Bank, click here.